---
title: "Daiwa Reaffirms Their Buy Rating on WuXi AppTec Co., Ltd. Class H (2359)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295593791.md"
description: "Daiwa reaffirmed its Buy rating on WuXi AppTec (2359) on August 10, setting a price target of HK$230.00, up from the closing price of HK$198.00. The analyst consensus remains a Strong Buy with an average target of HK$204.80. Additionally, Jefferies maintained a Buy rating with a HK$210.00 target in a report released on August 4."
datetime: "2026-08-12T00:26:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295593791.md)
  - [en](https://longbridge.com/en/news/295593791.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295593791.md)
generator: "portal-rs"
---

# Daiwa Reaffirms Their Buy Rating on WuXi AppTec Co., Ltd. Class H (2359)

Daiwa analyst maintained a Buy rating on WuXi AppTec Co., Ltd. Class H on August 10 and set a price target of HK$230.00. The company’s shares closed yesterday at HK$198.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Currently, the analyst consensus on WuXi AppTec Co., Ltd. Class H is a Strong Buy with an average price target of HK$204.80, a 3.43% upside from current levels. In a report released on August 4, Jefferies also maintained a Buy rating on the stock with a HK$210.00 price target.

### Related Stocks

- [02359.HK](https://longbridge.com/en/quote/02359.HK.md)
- [603259.CN](https://longbridge.com/en/quote/603259.CN.md)

## Related News & Research

- [Judge blocks US decision to add WuXi to list of companies tied to Chinese military](https://longbridge.com/en/news/295268371.md)
- [M Stanley Expects APPTEC  Share Price to Rise in Absolute Terms Over Next 30 Days](https://longbridge.com/en/news/294758238.md)
- [Halozyme Buy Rating Reiterated as VYVGART Hytrulo Data Support Royalty Growth; $115 Price Target Unchanged](https://longbridge.com/en/news/296135927.md)
- [12:05 ETD.Law Launches "The Champion," a New Newsletter Dedicated to Educating California Workers on Their Rights](https://longbridge.com/en/news/296379439.md)
- [Ocular Therapeutix Earns Buy Rating as Axpaxli Differentiation and LUGANO TKI Data Bolster Confidence in Lead Asset](https://longbridge.com/en/news/296129081.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**